Orange Book product · Brand (NDA)
ELIGARD KIT
LEUPROLIDE ACETATE
At a glance
Feb 13, 2003
Approved
Brand (NDA)
Application
Not listed
TE code
3
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Feb 13, 2003
23 yr 8 mo ago
Today
Patent 11771841 expires
Listed drug substance patent expiration.
Dec 22, 2041
in 15 yr 9 mo
Patent 11931559 expires
Listed drug substance patent expiration.
Dec 22, 2041
in 15 yr 9 mo
Patent 12397120 expires
Listed method-of-use patent (U-4001) expiration.
Dec 22, 2041
in 15 yr 9 mo
Pharmaceutical detail
Active ingredient
LEUPROLIDE ACETATE
Strength
30MG
Dosage form
POWDER
Route
SUBCUTANEOUS
TE code
Not listed
Application
NDA 021488
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2020FENSOLVI KITBrand (NDA)
NDA 213150 · TOLMAR
- 2018LEUPROLIDE ACETATE FOR DEPOT SUSPENSIONBrand (NDA)
NDA 205054 · INVAGEN PHARMS
- 2004ELIGARD KITBrand (NDA)
NDA 021731 · TOLMAR
- 2002ELIGARD KITBrand (NDA)
NDA 021379 · TOLMAR
- 2002ELIGARD KITBrand (NDA)
NDA 021343 · TOLMAR
- 2000VIADURBrand (NDA)
NDA 021088 · ORTHO MCNEIL JANSSEN
- 1997LUPRON DEPOTBrand (NDA)
NDA 020708 · ABBVIE ENDOCRINE INC
- 1995LUPRON DEPOTBrand (NDA)
NDA 020517 · ABBVIE ENDOCRINE INC
- 1993LUPRON DEPOT-PED KITBrand (NDA)
NDA 020263 · ABBVIE ENDOCRINE INC
- 1990LUPRON DEPOTBrand (NDA)
NDA 020011 · ABBVIE ENDOCRINE INC
- 1989LUPRON DEPOTBrand (NDA)
NDA 019732 · ABBVIE ENDOCRINE INC
- 1985LUPRONBrand (NDA)
NDA 019010 · ABBVIE ENDOCRINE INC
Listed patents (3)
| Patent | Expires | In | Type |
|---|---|---|---|
| 11771841 | Dec 22, 2041 | in 15 yr 9 mo | SubstanceProduct |
| 11931559 | Dec 22, 2041 | in 15 yr 9 mo | Substance |
| 12397120 | Dec 22, 2041 | in 15 yr 9 mo | U-4001 |

